Skip to main content
. 2018 Jun 1;14:55. doi: 10.1186/s12992-018-0369-2

Table 1.

Description of Options A, B and B+ and level of evidence

Option Year of WHO guideline Regimen for woman Regimen for infant GRADE rating
Treatment (CD4 ≤ 350) Prophylaxis (CD4 > 350)
Option A 2010a ART Pregnancy: AZT
Labour: single-dose NVP & AZT/3TC
Postpartum: AZT/3TC 7 days
NVP to 1 week after breastfeeding, or 4–6 weeks if not breastfeeding Strong recommendation
Low-quality evidence
Option B 2010 & 2013 ART Pregnancy and labour: triple ARVs
Postpartum until 1 week after breastfeeding
NVP or AZT for 4–6 weeks 2010: Strong recommendation moderate evidence
2013: Conditional recommendation
Low-quality evidence
Option B+ 2013 ART, regardless of CD4 count NVP or AZT for 4–6 weeks Conditional recommendation
Low-quality evidence

aOption B+ included as a research priority in these guidelines